Logo
x

Search category

Subscribe Now

All Posts by Date

HUTCHMED Reports the Completion of Patient Enrollment of Amdizalisib in P-II Registration Trial for Follicular Lymphoma in China

HUTCHMED Reports the Completion of Patient Enrollment of Amdizalisib in P-II Registration Trial for Follicular Lymphoma in China

  • February 27, 2023
Steffen-Sebastian Bolz, CSO of Aphaia Pharma Shares Insights from the P-II Study for Chronic Weight Management in Individuals with Obesity

Steffen-Sebastian Bolz, CSO of Aphaia Pharma Shares Insights from the P-II Study for Chronic Weight Management in Individuals with...

  • February 27, 2023
AbbVie Receives EMA’s CHMP Positive Opinion of Rinvoq (upadacitinib) for Crohn's Disease

AbbVie Receives EMA’s CHMP Positive Opinion of Rinvoq (upadacitinib) for Crohn's Disease

  • February 27, 2023
Exclusive Coverage: Global PHT Expo & Summit 2023

Exclusive Coverage: Global PHT Expo & Summit 2023

  • February 27, 2023
Medtronic Reports One Year (ADAPT) Study Results of MiniMed 780G Advanced Hybrid Closed Loop System for Type 1 Diabetes

Medtronic Reports One Year (ADAPT) Study Results of MiniMed 780G Advanced Hybrid Closed Loop System for Type 1 Diabetes

  • February 27, 2023
Blueprint Medicines Presents P-II Trial (PIONEER) of Ayvakit (avapritinib) for Indolent Systemic Mastocytosis at AAAAI 2023

Blueprint Medicines Presents P-II Trial (PIONEER) of Ayvakit (avapritinib) for Indolent Systemic Mastocytosis at AAAAI 2023

  • February 27, 2023
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.